Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Achievement of a Pharmacodynamic Target of Piperacillin-Tazobactam for the Population With Obesity: an Open Randomized Controlled Feasibility Study

NCT06690905 is registered in ClinicalTrials.gov with CR-CSSS Champlain-Charles-Le Moyne as lead sponsor.

NCT NCT06690905
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06690905 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Achievement of a Pharmacodynamic Target of Piperacillin-Tazobactam for the Population With Obesity: an Open Randomized Controlled Feasibility Study
Lead sponsor
CR-CSSS Champlain-Charles-Le Moyne
Phase
Phase 4
Overall status
Completed
Start date
February 26, 2025
Completion date
November 27, 2025
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infections, obesity and obesity-related medical conditions